Dr Agarwal's Hea, a company in the Hospital industry, reported revenue of ₹655 crore and net profit of ₹57 crore for the September 2026 quarter.
Dr Agarwal's Hea (NSE: AGARWALEYE) closed at ₹553.40 on 20 Nov 2026, up 11.8% over the past year. Its market capitalisation is ₹17,545 crore and it trades at 98.0 times earnings.
Incorporated in 2010, Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.